Clinical Trial Update: Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with cetuximab as first-line therapy for advanced/metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Cheryl Pugh | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED